Deferred Tax Assets, Valuation Allowance of PALVELLA THERAPEUTICS, INC. from 31 Dec 2013 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
PALVELLA THERAPEUTICS, INC. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2013 to 31 Dec 2024.
  • PALVELLA THERAPEUTICS, INC. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $93,254,000, a 482% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

PALVELLA THERAPEUTICS, INC. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $93,254,000 +$77,240,000 +482% 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q4 2023 $16,014,000 -$44,538,000 -74% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q4 2022 $60,552,000 +$7,345,000 +14% 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q4 2021 $53,207,000 +$9,474,000 +22% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q4 2020 $43,733,000 +$9,767,000 +29% 31 Dec 2020 10-K 02 Mar 2022 2021 FY
Q4 2019 $33,966,000 +$3,150,000 +10% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q4 2018 $30,816,000 +$5,566,000 +22% 31 Dec 2018 10-K 13 Mar 2020 2019 FY
Q4 2017 $25,250,000 +$5,433,000 +27% 31 Dec 2017 10-K 18 Mar 2019 2018 FY
Q4 2016 $19,817,000 +$5,915,035 +43% 31 Dec 2016 10-K 15 Mar 2018 2017 FY
Q4 2015 $13,901,965 +$3,985,412 +40% 31 Dec 2015 10-K 30 Mar 2017 2016 FY
Q4 2014 $9,916,553 -$7,137,214 -42% 31 Dec 2014 10-K 23 Mar 2016 2015 FY
Q4 2013 $17,053,767 31 Dec 2013 10-K 30 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.